...
首页> 外文期刊>Stem cells international >Mesenchymal Stromal Cells from Osteoarthritic Synovium Are a Distinct Population Compared to Their Bone-Marrow Counterparts regarding Surface Marker Distribution and Immunomodulation of Allogeneic CD4+T-Cell Cultures
【24h】

Mesenchymal Stromal Cells from Osteoarthritic Synovium Are a Distinct Population Compared to Their Bone-Marrow Counterparts regarding Surface Marker Distribution and Immunomodulation of Allogeneic CD4+T-Cell Cultures

机译:与其骨髓对应物相比,来自骨关节炎的间充质基质细胞是一种与其对同种异体CD4 + T细胞培养物的表面标志物分布和免疫调节相比的不同群体

获取原文
获取原文并翻译 | 示例

摘要

Introduction. The participation of an inflammatory joint milieu has been described in osteoarthritis (OA) pathogenesis. Mesenchymal stromal cells (MSCs) play an important role in modulating inflammatory processes. Based on previous studies in an allogeneic T-cell coculture model, we aimed at further determining the role of synovial MSCs in OA pathogenesis. Methods. Bone-marrow (BM) and synovial membrane (SM) MSCs from hip joints of late stage OA patients and CD4+ T-cells from healthy donors were analysed regarding surface marker expression before and after coculture. Proliferation upon CD3/CD28 stimulation and cytokine analyses were compared between MSCs. Results. SM-MSCs differed from BM-MSCs in several surface markers and their osteogenic differentiation potential. Cocultures of both MSCs with CD4+ T-cells resulted in recruitment of CD45RA+ FoxP3+ regulatory T-cells. Upon stimulation, only SM-MSCs suppressed CD4+ T-cell proliferation, while both SM-MSCs and BM-MSCs modified cytokine profiles through suppressing IL-2 and TNF-alpha. as well as increasing IL-6 secretion. Conclusions. Synovial MSCs from OA joints are a unique fraction that can be distinguished from their bone-marrow derived counterparts. Their unique ability to suppress CD3/CD28 induced CD4+ T-cell proliferation makes them a potential target for future therapeutic approaches.
机译:介绍。炎症关节Milieu的参与已在骨关节炎(OA)发病机制中描述。间充质基质细胞(MSCs)在调节炎症过程中起重要作用。基于以往的同种异体T细胞共培养模型的研究,我们旨在进一步确定Synovial MSCs在OA发病机制中的作用。方法。从晚期OA患者的髋关节和来自健康供体的CD4 + T细胞的髋关节的骨髓(BM)和滑膜(SM)MSC分析了聚集论前后的表面标志物表达。在MSC之间比较了CD3 / CD28刺激和细胞因子分析的增殖。结果。 SM-MSCs在几种表面标记中与BM-MSCs不同,其成骨分化潜力不同。 MSCs的共科患者与CD4 + T细胞导致CD45ra + Foxp3 +调节性T细胞的募集。在刺激后,只有SM-MSCs抑制CD4 + T细胞增殖,而SM-MSC和BM-MSCs都通过抑制IL-2和TNF-α改性细胞因子谱。以及增加IL-6分泌物。结论。来自OA关节的滑膜MSC是可以与其骨髓衍生的对应物区分开的独特分数。它们独特的抑制CD3 / CD28诱导的CD4 + T细胞增殖能力使它们成为未来治疗方法的潜在目标。

著录项

  • 来源
    《Stem cells international 》 |2016年第8期| 共17页
  • 作者单位

    Univ Heidelberg Hosp Ctr Orthoped Trauma Surg &

    Spinal Cords Injury Clin Orthoped &

    Trauma Surg;

    Univ Heidelberg Hosp Ctr Orthoped Trauma Surg &

    Spinal Cords Injury Clin Orthoped &

    Trauma Surg;

    Univ Heidelberg Hosp Ctr Orthoped Trauma Surg &

    Spinal Cords Injury Clin Orthoped &

    Trauma Surg;

    Univ Heidelberg Hosp Ctr Orthoped Trauma Surg &

    Spinal Cords Injury Clin Orthoped &

    Trauma Surg;

    Univ Heidelberg Hosp Ctr Orthoped Trauma Surg &

    Spinal Cords Injury Clin Orthoped &

    Trauma Surg;

    Univ Heidelberg Hosp Ctr Orthoped Trauma Surg &

    Spinal Cords Injury Clin Orthoped &

    Trauma Surg;

    Univ Heidelberg Hosp Ctr Orthoped Trauma Surg &

    Spinal Cords Injury Clin Orthoped &

    Trauma Surg;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物工程学(生物技术) ;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号